The purpose of this study is to test the safety and efficacy of GW679769 and paroxetine in
subjects with Social Anxiety Disorder
Minimum age: 18 Years.
Maximum age: 65 Years.
Gender(s): Both.
Inclusion Criteria:
- Patients with Generalized Social Anxiety Disorder as the primary diagnosis.
- If female, must commit to consistent and correct use of an acceptable method of birth
control.
Exclusion Criteria:
- Patients with any other psychiatric disorder as a primary diagnosis or within 6
months prior to screening.
- Patients with Body Dysmophic Disorder, Schizophrenia, Schizoaffective Disorder, or a
Bipolar Disorder.
- Patients who pose a current suicidal or homicidal risk or have made a suicide attempt
within the past 6 months or have ever been homicidal.
- Patients who have a positive urine test at screen for illegal drug use and/or a
history of substance abuse or dependence (alcohol or drugs) within the past 12
months.
- Patients with an unstable medical disorder.
- Female patients who are pregnant, lactating, or planning to become pregnant during a
specified time during the study.
- Patients who are taking other psychoactive medications.
GSK Investigational Site, Buenos Aires C1122AAN, Argentina
GSK Investigational Site, Ciudad Autonoma de Buenos Aires C1062ABF, Argentina
GSK Investigational Site, San José, Costa Rica
GSK Investigational Site, Mexico, D.F. 03740, Mexico
GSK Investigational Site, Edmonton, Alberta T6L 5X8, Canada
GSK Investigational Site, Kelowna, British Columbia V1Y 2H4, Canada
GSK Investigational Site, La Plata/Buenos Aires, Buenos Aires B1896AEH, Argentina
GSK Investigational Site, Beverly Hills, California 90210, United States
GSK Investigational Site, Burbank, California 91506, United States
GSK Investigational Site, Cordoba, Córdova 5000, Argentina
GSK Investigational Site, Jacksonville, Florida 32216, United States
GSK Investigational Site, Miami, Florida 33125, United States
GSK Investigational Site, North Miami, Florida 33161, United States
GSK Investigational Site, Orlando, Florida 32806, United States
GSK Investigational Site, Smyrna, Georgia 30080, United States
GSK Investigational Site, Oakbrook Terrace, Illinois 60181, United States
GSK Investigational Site, Rockville, Maryland 20852, United States
GSK Investigational Site, Miramichi, New Brunswick E1V 3G5, Canada
GSK Investigational Site, New York, New York 10021, United States
GSK Investigational Site, New York, New York 10024, United States
GSK Investigational Site, Monterrey, Nuevo León 64170, Mexico
GSK Investigational Site, Oklahoma City, Oklahoma 73104, United States
GSK Investigational Site, Philadelphia, Pennsylvania 19149, United States
GSK Investigational Site, Providencia / Santiago, Región Metro De Santiago 7500710, Chile
GSK Investigational Site, Santiago, Región Metro De Santiago 7580208, Chile
GSK Investigational Site, Lake Jackson, Texas 77566, United States